Skip to main content
Erschienen in: Obesity Surgery 8/2019

25.05.2019 | Review Article

Esophagogastric Neoplasms Following Bariatric Surgery: an Updated Systematic Review

verfasst von: Mario Musella, Giovanna Berardi, Alessio Bocchetti, Roberta Green, Valeria Cantoni, Nunzio Velotti, Katia Di Lauro, Domenico Manzolillo, Antonio Vitiello, Marco Milone, Giovanni Domenico De Palma

Erschienen in: Obesity Surgery | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

The risk of gastric and/or esophageal cancers after bariatric surgery has been previously discussed in literature. A systematic review was performed to identify articles published between June 2012 and December 2018 reporting new cases of esophageal or gastric cancer not included in previous systematic reviews. Ten gastric malignancies, 28 esophageal cancers, and 2 gastro-intestinal stromal tumors (GIST) were identified. Primary bariatric surgery was a restrictive procedure in 26 cases, a purely malabsorptive procedure in 1 subject, and a gastric bypass in 13 patients. Although the vast majority of bariatric procedures seem to present a negligible relationship with any esophagogastric (EG) malignancy, published data remain incomplete. It was however considered of interest to update the number of EG neoplasms arisen following bariatric surgery.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Phillips BT, Shikora SA. The history of metabolic and bariatric surgery: development of standards for patient safety and efficacy. Metabolism. 2018 Feb;79:97–107.PubMed Phillips BT, Shikora SA. The history of metabolic and bariatric surgery: development of standards for patient safety and efficacy. Metabolism. 2018 Feb;79:97–107.PubMed
3.
Zurück zum Zitat Scozzari G, Trapani R, Toppino M, et al. Esophagogastric cancer after bariatric surgery: systematic review of the literature. Surg Obes Relat Dis. 2013;9(1):133–42.PubMed Scozzari G, Trapani R, Toppino M, et al. Esophagogastric cancer after bariatric surgery: systematic review of the literature. Surg Obes Relat Dis. 2013;9(1):133–42.PubMed
4.
Zurück zum Zitat Orlando G, Pilone V, Vitiello A, et al. Gastric cancer following bariatric surgery: a review. Surg Laparosc Endosc Percutan Tech. 2014;24(5):400–5.PubMed Orlando G, Pilone V, Vitiello A, et al. Gastric cancer following bariatric surgery: a review. Surg Laparosc Endosc Percutan Tech. 2014;24(5):400–5.PubMed
5.
Zurück zum Zitat Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11(3):276–80.PubMed Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11(3):276–80.PubMed
6.
Zurück zum Zitat Carbajo M, García-Caballero M, Toledano M, et al. One-anastomosis gastric bypass by laparoscopy: results of the first 209 patients. Obes Surg. 2005;15(3):398–404.PubMed Carbajo M, García-Caballero M, Toledano M, et al. One-anastomosis gastric bypass by laparoscopy: results of the first 209 patients. Obes Surg. 2005;15(3):398–404.PubMed
7.
Zurück zum Zitat Fisher BL, Buchwald H, Clark W, et al. Mini-gastric bypass controversy. Obes Surg. 2001;11(6):773–7.PubMed Fisher BL, Buchwald H, Clark W, et al. Mini-gastric bypass controversy. Obes Surg. 2001;11(6):773–7.PubMed
8.
Zurück zum Zitat De Luca M, Tie T, Ooi G, et al. Mini gastric bypass-one anastomosis gastric bypass (MGB/OAGB)-IFSO position statement. Obes Surg. 2018;28(5):1188–206.PubMed De Luca M, Tie T, Ooi G, et al. Mini gastric bypass-one anastomosis gastric bypass (MGB/OAGB)-IFSO position statement. Obes Surg. 2018;28(5):1188–206.PubMed
9.
Zurück zum Zitat Mahawar KK, Himpens J, Shikora SA, et al. The first consensus statement on one anastomosis/mini gastric bypass (OAGB/MGB) using a modified Delphi approach. Obes Surg. 2018;28(2):303–12.PubMed Mahawar KK, Himpens J, Shikora SA, et al. The first consensus statement on one anastomosis/mini gastric bypass (OAGB/MGB) using a modified Delphi approach. Obes Surg. 2018;28(2):303–12.PubMed
11.
Zurück zum Zitat Genco A, Soricelli E, Casella G, et al. Gastroesophageal reflux disease and Barrett’s esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication. Surg Obes Relat Dis. 2017 Apr;13(4):568–74.PubMed Genco A, Soricelli E, Casella G, et al. Gastroesophageal reflux disease and Barrett’s esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication. Surg Obes Relat Dis. 2017 Apr;13(4):568–74.PubMed
12.
Zurück zum Zitat Angrisani L, Santonicola A, Iovino P, et al. IFSO worldwide survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018 Dec;28(12):3783–94.PubMed Angrisani L, Santonicola A, Iovino P, et al. IFSO worldwide survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018 Dec;28(12):3783–94.PubMed
13.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.PubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.PubMedPubMedCentral
14.
Zurück zum Zitat Miller SA. PICO worksheet and search strategy. US National Center for Dental Hygiene Research; 2001. Miller SA. PICO worksheet and search strategy. US National Center for Dental Hygiene Research; 2001.
16.
Zurück zum Zitat Menendez P, Villarejo P, Padilla D. Krukenberg tumor after gastric bypass for morbid obesity. Bariatric surgery and gastric cancer. Rev Esp Enferm Dig. 2013;105(5):296–8.PubMed Menendez P, Villarejo P, Padilla D. Krukenberg tumor after gastric bypass for morbid obesity. Bariatric surgery and gastric cancer. Rev Esp Enferm Dig. 2013;105(5):296–8.PubMed
17.
Zurück zum Zitat Abellán I, Ruíz de Angulo D, Parrilla P. Incidental gastric gastrointestinal stromal tumor (GIST) in the excluded stomach after Roux- en-Y gastric bypass: a case report and review of the literature. Surg Obes Relat Dis. 2014;10(1):e13–4.PubMed Abellán I, Ruíz de Angulo D, Parrilla P. Incidental gastric gastrointestinal stromal tumor (GIST) in the excluded stomach after Roux- en-Y gastric bypass: a case report and review of the literature. Surg Obes Relat Dis. 2014;10(1):e13–4.PubMed
18.
Zurück zum Zitat Rossidis G, Browning R, Hochwald SN, et al. Minimally invasive esophagectomy is safe in patients with previous gastric bypass. Surg Obes Relat Dis. 2014;10(1):95–100.PubMed Rossidis G, Browning R, Hochwald SN, et al. Minimally invasive esophagectomy is safe in patients with previous gastric bypass. Surg Obes Relat Dis. 2014;10(1):95–100.PubMed
19.
Zurück zum Zitat Wu CC, Lee WJ, Ser KH, et al. Gastric cancer after mini-gastric bypass surgery: a case report and literature review. Asian J Endosc Surg. 2013;6(4):303–6.PubMed Wu CC, Lee WJ, Ser KH, et al. Gastric cancer after mini-gastric bypass surgery: a case report and literature review. Asian J Endosc Surg. 2013;6(4):303–6.PubMed
20.
Zurück zum Zitat Scozzari G, Balmativola D, Trapani R, et al. Gastric Cancer after restrictive bariatric surgery: a clinical pitfall. Int J Surg Pathol. 2014;22(5):442–6.PubMed Scozzari G, Balmativola D, Trapani R, et al. Gastric Cancer after restrictive bariatric surgery: a clinical pitfall. Int J Surg Pathol. 2014;22(5):442–6.PubMed
21.
Zurück zum Zitat Angrisani L, Santonicola A, Iovino P. Gastric cancer: a de novo diagnosis after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2014;10(1):186–7.PubMed Angrisani L, Santonicola A, Iovino P. Gastric cancer: a de novo diagnosis after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2014;10(1):186–7.PubMed
22.
Zurück zum Zitat Erim T, Colak Y, Szomstein S. Gastric carcinoid tumor after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2015;11(6):e51–2.PubMed Erim T, Colak Y, Szomstein S. Gastric carcinoid tumor after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2015;11(6):e51–2.PubMed
23.
Zurück zum Zitat Masrur M, Elli E, Gonzalez-Ciccarelli LF, et al. De novo gastric adenocarcinoma 1 year after sleeve gastrectomy in a transplant patient. Int J Surg Case Rep. 2016;20:10–3.PubMedPubMedCentral Masrur M, Elli E, Gonzalez-Ciccarelli LF, et al. De novo gastric adenocarcinoma 1 year after sleeve gastrectomy in a transplant patient. Int J Surg Case Rep. 2016;20:10–3.PubMedPubMedCentral
24.
Zurück zum Zitat Maret-Ouda J, Tao W, Mattsson F, et al. Esophageal adenocarcinoma after obesity surgery in a population-based cohort study. Surg Obes Relat Dis. 2017;13(1):28–34.PubMed Maret-Ouda J, Tao W, Mattsson F, et al. Esophageal adenocarcinoma after obesity surgery in a population-based cohort study. Surg Obes Relat Dis. 2017;13(1):28–34.PubMed
25.
Zurück zum Zitat Tinoco A, Gottardi LF, Boechat ED. Gastric cancer in the excluded stomach 10 years after gastric bypass. Case Rep Surg. 2015;2015:468293.PubMedPubMedCentral Tinoco A, Gottardi LF, Boechat ED. Gastric cancer in the excluded stomach 10 years after gastric bypass. Case Rep Surg. 2015;2015:468293.PubMedPubMedCentral
26.
Zurück zum Zitat Burton PR, Ooi GJ, Laurie C, et al. Diagnosis and management of oesophageal cancer in bariatric surgical patients. J Gastrointest Surg. 2016;20(10):1683–91.PubMed Burton PR, Ooi GJ, Laurie C, et al. Diagnosis and management of oesophageal cancer in bariatric surgical patients. J Gastrointest Surg. 2016;20(10):1683–91.PubMed
27.
Zurück zum Zitat Vladimirov M, Hesse U, Stein HJ. Gastric carcinoma after sleeve gastrectomy for obesity. Surg Obes Relat Dis. 2017;13(8):1459–61.PubMed Vladimirov M, Hesse U, Stein HJ. Gastric carcinoma after sleeve gastrectomy for obesity. Surg Obes Relat Dis. 2017;13(8):1459–61.PubMed
28.
Zurück zum Zitat van de Vrande S, Himpens J, Leman G. Adenocarcinoma of the gastric pouch after Roux-en-Y gastric bypass: a new technique for en bloc resection and reconstruction. Surg Obes Relat Dis. 2017;13(10):1793–5.PubMed van de Vrande S, Himpens J, Leman G. Adenocarcinoma of the gastric pouch after Roux-en-Y gastric bypass: a new technique for en bloc resection and reconstruction. Surg Obes Relat Dis. 2017;13(10):1793–5.PubMed
29.
Zurück zum Zitat El Khoury L, Benvenga R, Romero R, et al. Esophageal adenocarcinoma in Barrett’s esophagus after sleeve gastrectomy: case report and literature review. Int J Surg Case Rep. 2018;52:132–6.PubMedPubMedCentral El Khoury L, Benvenga R, Romero R, et al. Esophageal adenocarcinoma in Barrett’s esophagus after sleeve gastrectomy: case report and literature review. Int J Surg Case Rep. 2018;52:132–6.PubMedPubMedCentral
31.
Zurück zum Zitat Christou NV, Lieberman M, Sampalis F, et al. Bariatric surgery reduces cancer risk in morbidly obese patients. Surg Obes Relat Dis. 2008;4(6):691–5.PubMed Christou NV, Lieberman M, Sampalis F, et al. Bariatric surgery reduces cancer risk in morbidly obese patients. Surg Obes Relat Dis. 2008;4(6):691–5.PubMed
32.
Zurück zum Zitat Gan L, Liu Z, Sun C. Obesity linking to hepatocellular carcinoma: a global view. Biochim Biophys Acta. 2018;1869(2):97–102. Gan L, Liu Z, Sun C. Obesity linking to hepatocellular carcinoma: a global view. Biochim Biophys Acta. 2018;1869(2):97–102.
33.
Zurück zum Zitat Kim WG, Cheng SY. Mechanisms linking obesity and thyroid cancer development and progression in mouse models. Horm Cancer. 2018;9(2):108–16.PubMed Kim WG, Cheng SY. Mechanisms linking obesity and thyroid cancer development and progression in mouse models. Horm Cancer. 2018;9(2):108–16.PubMed
34.
Zurück zum Zitat Maciejewski ML, Arterburn DE, Van Scoyoc L, et al. Bariatric surgery and long-term durability of weight loss. JAMA Surg. 2016;151:1046–55.PubMedPubMedCentral Maciejewski ML, Arterburn DE, Van Scoyoc L, et al. Bariatric surgery and long-term durability of weight loss. JAMA Surg. 2016;151:1046–55.PubMedPubMedCentral
35.
Zurück zum Zitat Schauer DP, Feigelson HS, Koebnick C, et al. Bariatric surgery and the risk of cancer in a large multisite cohort. Ann Surg. 2019;269(1):95–101.PubMed Schauer DP, Feigelson HS, Koebnick C, et al. Bariatric surgery and the risk of cancer in a large multisite cohort. Ann Surg. 2019;269(1):95–101.PubMed
36.
Zurück zum Zitat Johnson WH, Fernanadez AZ, Farrell TM, et al. Surgical revision of loop (“mini”) gastric bypass procedure: multicenter review of complications and conversions to Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2007;3:37–41.PubMed Johnson WH, Fernanadez AZ, Farrell TM, et al. Surgical revision of loop (“mini”) gastric bypass procedure: multicenter review of complications and conversions to Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2007;3:37–41.PubMed
37.
Zurück zum Zitat Collins BJ, Miyashita T, Schweitzer M, et al. Gastric bypass: why Roux-en-Y? A review of experimental data. Arch Surg. 2007;142:1000–3.PubMed Collins BJ, Miyashita T, Schweitzer M, et al. Gastric bypass: why Roux-en-Y? A review of experimental data. Arch Surg. 2007;142:1000–3.PubMed
38.
Zurück zum Zitat Guirat A, Addossari HM. One anastomosis gastric bypass and risk of cancer. Obes Surg. 2018;28(5):1441–4.PubMed Guirat A, Addossari HM. One anastomosis gastric bypass and risk of cancer. Obes Surg. 2018;28(5):1441–4.PubMed
39.
Zurück zum Zitat Felsenreich DM, Kefurt R, Schermann M, et al. Reflux, sleeve dilation, and Barrett’s esophagus after laparoscopic sleeve gastrectomy: long-term follow-up. Obes Surg. 2017;27(12):3092–101.PubMed Felsenreich DM, Kefurt R, Schermann M, et al. Reflux, sleeve dilation, and Barrett’s esophagus after laparoscopic sleeve gastrectomy: long-term follow-up. Obes Surg. 2017;27(12):3092–101.PubMed
40.
Zurück zum Zitat Musella M, Milone M, Deitel M, et al. What a mini/one anastomosis gastric bypass (MGB/OAGB) is. Obes Surg. 2016;26(6):1322–3.PubMed Musella M, Milone M, Deitel M, et al. What a mini/one anastomosis gastric bypass (MGB/OAGB) is. Obes Surg. 2016;26(6):1322–3.PubMed
41.
Zurück zum Zitat Musella M, Susa A, Manno E, et al. Complications following the mini/one anastomosis gastric bypass (MGB/OAGB): a multi-institutional survey on 2678 patients with a mid-term (5 years) follow-up. Obes Surg. 2017;27(11):2956–67.PubMed Musella M, Susa A, Manno E, et al. Complications following the mini/one anastomosis gastric bypass (MGB/OAGB): a multi-institutional survey on 2678 patients with a mid-term (5 years) follow-up. Obes Surg. 2017;27(11):2956–67.PubMed
42.
Zurück zum Zitat Musella M, Susa A, Greco F, et al. The laparoscopic mini-gastric bypass: the Italian experience: outcomes from 974 consecutive cases in a multicenter review. Surg Endosc. 2014;28(1):156–63.PubMed Musella M, Susa A, Greco F, et al. The laparoscopic mini-gastric bypass: the Italian experience: outcomes from 974 consecutive cases in a multicenter review. Surg Endosc. 2014;28(1):156–63.PubMed
44.
Zurück zum Zitat Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427–36.PubMed Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427–36.PubMed
45.
Zurück zum Zitat Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–87.PubMed Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–87.PubMed
47.
Zurück zum Zitat Singh S, Sharma AN, Murad MH, et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11(11):1399–1412.e7.PubMed Singh S, Sharma AN, Murad MH, et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11(11):1399–1412.e7.PubMed
48.
Zurück zum Zitat Samson P, Puri V, Broderick S, et al. Extent of lymphadenectomy is associated with improved overall survival after esophagectomy with or without induction therapy. Ann Thorac Surg. 2017;103(2):406–15.PubMed Samson P, Puri V, Broderick S, et al. Extent of lymphadenectomy is associated with improved overall survival after esophagectomy with or without induction therapy. Ann Thorac Surg. 2017;103(2):406–15.PubMed
49.
Zurück zum Zitat Gadde R, Tamariz L, Hanna M, et al. Metastatic gastric cancer (MGC) patients: can we improve survival by metastasectomy? A systematic review and meta-analysis. J Surg Oncol. 2015;112(1):38–45.PubMed Gadde R, Tamariz L, Hanna M, et al. Metastatic gastric cancer (MGC) patients: can we improve survival by metastasectomy? A systematic review and meta-analysis. J Surg Oncol. 2015;112(1):38–45.PubMed
50.
Zurück zum Zitat Blum Murphy MA, Elimova E, Ajani JA. Current concepts and future potential in neoadjuvant chemotherapy for esophageal cancer. Expert Rev Gastroenterol Hepatol. 2016;10(3):383–92.PubMed Blum Murphy MA, Elimova E, Ajani JA. Current concepts and future potential in neoadjuvant chemotherapy for esophageal cancer. Expert Rev Gastroenterol Hepatol. 2016;10(3):383–92.PubMed
51.
Zurück zum Zitat Braghetto I, Csendes A. Single anastomosis gastric bypass (one anastomosis gastric bypass or mini gastric bypass): the experience with billroth II must be considered and is a challenge for the next years. Arq Bras Cir Dig. 2017;30(4):267–71.PubMedPubMedCentral Braghetto I, Csendes A. Single anastomosis gastric bypass (one anastomosis gastric bypass or mini gastric bypass): the experience with billroth II must be considered and is a challenge for the next years. Arq Bras Cir Dig. 2017;30(4):267–71.PubMedPubMedCentral
52.
Zurück zum Zitat Deitel M, Crosby RD, Gagner M. The first international consensus summit for sleeve gastrectomy (SG), New York City, October 25-27, 2007. Obes Surg. 2008;18(5):487–96.PubMed Deitel M, Crosby RD, Gagner M. The first international consensus summit for sleeve gastrectomy (SG), New York City, October 25-27, 2007. Obes Surg. 2008;18(5):487–96.PubMed
Metadaten
Titel
Esophagogastric Neoplasms Following Bariatric Surgery: an Updated Systematic Review
verfasst von
Mario Musella
Giovanna Berardi
Alessio Bocchetti
Roberta Green
Valeria Cantoni
Nunzio Velotti
Katia Di Lauro
Domenico Manzolillo
Antonio Vitiello
Marco Milone
Giovanni Domenico De Palma
Publikationsdatum
25.05.2019
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 8/2019
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-019-03951-z

Weitere Artikel der Ausgabe 8/2019

Obesity Surgery 8/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.